MabVax Therapeutics (MBVX) Signs Pact with MSK to Develop Novel CAR T-Cell Based Anti-Cancer ImmunotherapiesStreetInsider.comUnder the new agreement, MabVax will provide funding to evaluate the efficacy of multiple CAR T-cell products incorporating sev… Continue reading
|
Cancer meeting to provide clues on future immunotherapy combos
Reuters As a wider range of drugs that enlist the body’s immune system to fight cancer become available, clues about which combinations will prove most effective are expected at the upcoming meeting of the American Society of Clinical Oncology. The ASCO … |
|
Regenxbio (RGNX) Begins Phase I Trial of RGX-314 Gene Therapy for Wet AMD
StreetInsider.com REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced that the first patient was dosed … |
Spectrum |
BioEden – Autistic Children’s Early Success Stories From Tooth Stem Cells
PR Newswire (press release) Twenty individuals, ranging from the ages of 2 to 43, have become the first to use stem cells from their teeth in the treatment of various conditions including cerebral palsy, diabetes, cleft lip, and autism. The cells in use are dental pulp stem cells … Controversial trial of cord blood therapy for autism forges aheadSpectrum |
|
Novartis isn’t messing around with CAR–T, and it has a promising next-gen therapy to help prove it
Endpoints News Novartis made one of the biggest splashes when it jumped into CAR–T — reengineering patients’ immune cells to attack cancer cells — with Carl June and his colleagues at Penn. And the Big Pharma player stunned the oncology field last summer when it … |
STAT |
Startup Spotlight: Finding a better way to open cells to CRISPR
STAT here are many ways to get CRISPR into a cell. Viruses will do the trick. Squeezing a cell will also work 1. A surge of electricity can also open up pores in a cell’s membrane. So some companies — anticipating an impending genome-editing gold rush … |
ProHealth |
StemGenex Applauds Kelly Osbourne for Supporting Stem Cell Therapy
ProHealth “We at StemGenex applaud Kelly Osbourne for her outspoken support of stem cell therapy,” said Rita Alexander, the organization’s Chief Administrative Officer. “At StemGenex, we have witnessed how the use of adipose-derived stem cells (from fat tissue) … |
ProHealth |
StemGenex Applauds Kelly Osbourne for Supporting Stem Cell Therapy
ProHealth “We at StemGenex applaud Kelly Osbourne for her outspoken support of stem cell therapy,” said Rita Alexander, the organization’s Chief Administrative Officer. “At StemGenex, we have witnessed how the use of adipose-derived stem cells (from fat tissue) … |